Quality & complianceOfficial
Class II drug recall: fentaNYL Citrate (Ourpharma Llc)
🇺🇸 FDA enforcement report · Wed 16 Sep 2026
Labeling: Not Elsewhere Classified: Complaint received on 08/31/2026 regarding the discrepancy of the IV bag expiry (07/31/2026 and 11/30/2026) and the product expiry (12/09/2026). Recall D-0864-2026; status Ongoing; distribution: Nationwide within the U.S.
Official source: FDA enforcement report ↗
Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.
More Quality & compliance
All →
BfArM publishes Vascutek field safety notice for Gelweave vascular prosthesis
🇩🇪 BfArM field safety notices · Fri 13 Nov 2026
BfArM publishes urgent field safety notice for Löwenstein Medical's LEONI 4 device
🇩🇪 BfArM field safety notices · Fri 13 Nov 2026
Health Canada flags Pendopharm's Secaris Nasal Gel lot over possible foreign matter
🇨🇦 Health Canada · Fri 13 Nov 2026
BfArM lists urgent field safety notice for Philips IntelliVue Patient Monitor
🇩🇪 BfArM field safety notices · Fri 13 Nov 2026
BfArM lists urgent field safety notice for EPflex guidewires
🇩🇪 BfArM field safety notices · Fri 13 Nov 2026
BfArM publishes QuidelOrtho field safety notice for VITROS A1c Slides
🇩🇪 BfArM field safety notices · Fri 13 Nov 2026